topamax sales migraine versus epilepsy
Today, the US Food and Drug Administration approved several indications and other updates to the label of capecitabine tablets (Xeloda) under the agency’s Project Renewal initiative. The goal of this pilot program, established by the agency’s Oncology Center of Excellence, is to update labeling information for older oncology drugs to ensure the indications are clinically meaningful and scientifically up to […]
Continue reading »